Together, we CAN! When Zach was diagnosed with Angelman Syndrome (AS) about 12 years ago, we heard that a lot of things wouldn't be possible. That didn't stop him or us from taking on each challenge and overcoming many.
Since that time many dedicated researchers and FAST and others in the AS community have worked to prove several treatments to reverse the devastating symptoms of AS. FAST and UPENN are partnering to bring a gene therapy to people with AS within the next 2-3 years. It's very promising -- and expensive. The gene therapies and therapeutics under development right now towards treatment in humans in the next couple years will not only change the lives of almost 500,000 people with AS, but their families and caregivers, and will likely provide a path for treatment of millions more people with related disorders including Autism and Alzheimer's.
Want to make a real and lasting difference in millions of people's lives? Please join us now in accelerating a Cure for Angelman Syndrome Now!